Lakefront Biotherapeutics (LKFT)
29.52
-0.48
(-1.60%)
USD |
NASDAQ |
Oct 08, 16:00
29.52
0.00 (0.00%)
After-Hours: 19:06
Lakefront Biotherapeutics Profit Margin (Quarterly) : 16.05% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 16.05% |
| March 31, 2026 | |
| December 31, 2025 | 86.86% |
| September 30, 2025 | -286.7% |
| June 30, 2025 | -160.0% |
| March 31, 2025 | -206.1% |
| December 31, 2024 | 25.33% |
| September 30, 2024 | -81.15% |
| June 30, 2024 | 5.99% |
| March 31, 2024 | 37.65% |
| September 30, 2023 | 71.20% |
| June 30, 2023 | 6.45% |
| March 31, 2023 | -19.11% |
| December 31, 2022 | -217.8% |
| September 30, 2022 | 15.82% |
| June 30, 2022 | -13.83% |
| March 31, 2022 | -9.76% |
| December 31, 2021 | 9.79% |
| September 30, 2021 | -100.7% |
| June 30, 2021 | -46.02% |
| March 31, 2021 | -11.26% |
| December 31, 2020 | -43.92% |
| September 30, 2020 | -64.71% |
| June 30, 2020 | -117.5% |
| March 31, 2020 | -55.11% |
| Date | Value |
|---|---|
| December 31, 2019 | -96.83% |
| September 30, 2019 | 56.98% |
| June 30, 2019 | -80.44% |
| March 31, 2019 | -147.2% |
| December 31, 2018 | 14.06% |
| September 30, 2018 | 15.64% |
| June 30, 2018 | -43.83% |
| March 31, 2018 | -98.35% |
| December 31, 2017 | -76.11% |
| September 30, 2017 | -135.9% |
| June 30, 2017 | -132.3% |
| March 31, 2017 | -40.02% |
| December 31, 2016 | 57.79% |
| September 30, 2016 | -215.5% |
| June 30, 2016 | -12.98% |
| March 31, 2016 | |
| December 31, 2015 | -792.6% |
| September 30, 2015 | -477.2% |
| December 31, 2005 | -10.91% |
| September 30, 2005 | -208.9% |
| June 30, 2005 | |
| March 31, 2005 | |
| December 31, 2004 | 17.94% |
| September 30, 2004 | -101.9% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Gilead Sciences, Inc. | -134.2% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alkermes Plc | 0.10% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Amarin Corp. Plc | -18.12% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 20.02% |
| Return on Assets | 16.99% |
| Return on Invested Capital | 19.97% |
| Gross Profit Margin (Quarterly) | 24.48% |
| Operating Margin (Quarterly) | -372.1% |
| Return on Net Operating Assets | 176.9% |